PH21926A - 6-phenyl-1,2,4-triazine derivatives - Google Patents

6-phenyl-1,2,4-triazine derivatives

Info

Publication number
PH21926A
PH21926A PH31367A PH31367A PH21926A PH 21926 A PH21926 A PH 21926A PH 31367 A PH31367 A PH 31367A PH 31367 A PH31367 A PH 31367A PH 21926 A PH21926 A PH 21926A
Authority
PH
Philippines
Prior art keywords
phenyl
triazine derivatives
triazine
derivatives
Prior art date
Application number
PH31367A
Other languages
English (en)
Inventor
Geoffrey Allan
Alistair Ainslie Miller
David Alan Sawyer
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of PH21926A publication Critical patent/PH21926A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH31367A 1983-10-27 1984-10-26 6-phenyl-1,2,4-triazine derivatives PH21926A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838328757A GB8328757D0 (en) 1983-10-27 1983-10-27 Chemical compounds

Publications (1)

Publication Number Publication Date
PH21926A true PH21926A (en) 1988-04-08

Family

ID=10550834

Family Applications (1)

Application Number Title Priority Date Filing Date
PH31367A PH21926A (en) 1983-10-27 1984-10-26 6-phenyl-1,2,4-triazine derivatives

Country Status (21)

Country Link
US (1) US4649139A (ru)
EP (1) EP0142306A3 (ru)
JP (1) JPS60109577A (ru)
KR (1) KR890000991B1 (ru)
AU (1) AU564667B2 (ru)
CA (1) CA1261328A (ru)
DD (1) DD224033A5 (ru)
DK (1) DK512184A (ru)
ES (1) ES8606304A1 (ru)
FI (1) FI844212L (ru)
GB (1) GB8328757D0 (ru)
GR (1) GR80723B (ru)
HU (1) HU191566B (ru)
IL (1) IL73332A (ru)
MC (1) MC1628A1 (ru)
NZ (1) NZ210000A (ru)
PH (1) PH21926A (ru)
PL (1) PL144899B1 (ru)
PT (1) PT79416B (ru)
SU (1) SU1371500A3 (ru)
ZA (1) ZA848388B (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
GB9218113D0 (en) * 1992-08-26 1992-10-14 Lilly Industries Ltd Pharmaceutical compounds
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds
AU763244B2 (en) * 2000-01-03 2003-07-17 Rpg Life Sciences Limited A process for the preparation of 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, commonly known as lamotrigine
IL134730A (en) * 2000-02-25 2003-10-31 Chemagis Ltd Process for preparing substituted benzoyl cyanide amidinohydrazones
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
GB0613836D0 (en) * 2006-07-13 2006-08-23 Univ Greenwich New medical use of triazine derivatives
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
GB0800741D0 (en) * 2008-01-16 2008-02-20 Univ Greenwich Cyclic triazo and diazo sodium channel blockers
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
GB2471713A (en) * 2009-07-08 2011-01-12 Univ Greenwich 1,2,4-triazine derivatives and their use as sodium channel blockers
GB2471729A (en) 2009-07-08 2011-01-12 Univ Greenwich 1,2,4-triazine derivatives and their use as sodium channel blockers
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2016198878A1 (en) 2015-06-12 2016-12-15 University Of Greenwich Triazine derivatives as interferon-gamma inhibitors
CN109810070B (zh) * 2019-01-29 2022-03-15 太原理工大学 一种含有双酰氧基结构的三嗪酮衍生物及其制备方法和应用
GB202006080D0 (en) 2020-04-24 2020-06-10 Univ Greenwich Cytokine storm syndrome
GB202006076D0 (en) 2020-04-24 2020-06-10 Univ Greenwich Interleukin inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB759014A (en) * 1952-02-26 1956-10-10 Wellcome Found Improvements in triazines and their manufacture
BG15760A3 (bg) * 1968-06-29 1976-06-21 Неизвестен Метод за получаване на производни на 5-имино- 1, 2, 4- триазина
US3637688A (en) * 1970-01-09 1972-01-25 American Home Prod 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
DE2003144C3 (de) * 1970-01-24 1980-01-10 Bayer Ag, 5090 Leverkusen 5-Imino-6-alkyl-1^2,4-triazin-Derivate und Verfahren zu deren Herstellung
EP0021120B1 (en) * 1979-06-01 1983-04-06 The Wellcome Foundation Limited 3,5-diamino-1,2,4-triazine derivatives, process for preparing such compounds and pharmaceutical compositions containing them
CS234018B2 (en) * 1979-06-01 1985-03-14 Wellcome Found Method of 3,5-diammino-6-1,2,4-triazine derivatives making
US4616014A (en) * 1981-10-22 1986-10-07 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same

Also Published As

Publication number Publication date
SU1371500A3 (ru) 1988-01-30
KR890000991B1 (ko) 1989-04-15
EP0142306A2 (en) 1985-05-22
GR80723B (en) 1985-02-07
IL73332A (en) 1988-06-30
HUT36102A (en) 1985-08-28
PL250213A1 (en) 1985-12-03
HU191566B (en) 1987-03-30
ZA848388B (en) 1986-06-25
ES537104A0 (es) 1986-04-16
GB8328757D0 (en) 1983-11-30
CA1261328A (en) 1989-09-26
NZ210000A (en) 1987-08-31
DD224033A5 (de) 1985-06-26
IL73332A0 (en) 1985-01-31
PL144899B1 (en) 1988-07-30
PT79416A (en) 1984-11-01
DK512184A (da) 1985-04-28
FI844212A0 (fi) 1984-10-26
ES8606304A1 (es) 1986-04-16
KR850002964A (ko) 1985-05-28
DK512184D0 (da) 1984-10-26
JPS60109577A (ja) 1985-06-15
MC1628A1 (fr) 1985-09-26
AU564667B2 (en) 1987-08-20
PT79416B (en) 1986-11-13
AU3475884A (en) 1985-05-09
US4649139A (en) 1987-03-10
EP0142306A3 (en) 1986-11-20
FI844212L (fi) 1985-04-28

Similar Documents

Publication Publication Date Title
IL80463A (en) 2-desoxy-2,2-difluoro-furanose derivatives
PH21926A (en) 6-phenyl-1,2,4-triazine derivatives
KR870001234B1 (en) 2,6-substituted compound
ZA847535B (en) 1,3-diaryl-5-methylene-perhydropyrimidin-2-ones
CS604984A2 (en) Zpusob tepelneho stepeni 1,2 dichloretanu
GB2160525B (en) 8,10-dideazaminopterins
AU566022B2 (en) 1,(2-aryl-2-halo-1-ethenyl)-1 h-azoles
GB2153816B (en) 4,5,6,7,-tetrahydrothiazolo5,4-cpyridine derivative
GB2140007B (en) 1,8-dihydroxy-10-acyl-9-anthrones
GB2145410B (en) 1,3-dioxane derivatives
CS620984A2 (en) Zpusob izolace 2-naftylamin-3,6,8-trisulfonove kyseliny
GB2156354B (en) 1,23-dihydroxyvitamin d compounds
CS39084A2 (en) Zpusob stanoveni obsahu kyseliny v oleji, zejmena v chladicich zarizenich pohanenych freonem
GB2148887B (en) 1,3-7 oxazino4,3-a-7
DE3461086D1 (en) 1,4-dihydropyridine derivatives
GB8411250D0 (en) 4,4'-alkylenedipiperidine derivatives
CS760383A1 (en) Sposob vyroby 1,1 azobisformamidu
CS378583A1 (en) Sposob vyroby 1,1 azobisformamidu
CS648483A1 (en) Sposob vyroby 2,2 azobisizobutyronitrilu
CS850684A2 (en) Zpusob vyroby neprasivych chinaxalin 1,4 di n oxidu
CS1024484A2 (en) Zpusob vyroby 3,4,5 trimethoxybenzonitrilu
GB2137622B (en) 1,4-dihydropyridine derivatives
GB2152036B (en) 4,5,6,7-tetrahydrobenzimidazole derivatives
SU1127272A1 (ru) 11,13- диметил-5-тиа -1,9-диазатрицикло 9,3,1,1гексадекан -2,8,12-трион
GB8304661D0 (en) 2,6-dichloropyrazine